November 24, 2010 – Results for a trial comparing a drug-eluting stent to balloon angioplasty and bare metal stenting in treating restenosis after angioplasty were announced at the VEITHsymposium. The Zilver PTX drug-eluting stent met the trial's 12-month primary endpoints.

The stent has CE mark approval in Europe for the superficial femoral artery.

November 24, 2010 – Researchers at Northwestern are utilizing a patient’s own stem cells to regenerate heart and vascular tissue, offering a potential new treatment for cardiovascular disease. Northwestern Medicine is the lead site for a study examining stem cell transplantation as treatment for critical limb ischemia.

November 24, 2010 – Cardiologists and primary care physicians now perceive AstraZeneca's Crestor as comparable to Pfizer’s Lipitor in treating and reducing mortality in dyslipidemia patients, according to a survey by Decision Resources.

This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better.

November 24, 2010 - Rotational computed tomography angiography (CTA), a new noninvasive imaging modality, has the ability to display angiography in 3-D formats. This allows for considerable simplification of orientation of complex fenestrated/branched stent grafts in 3-D views, as well as catheterization of target vessels.

November 23, 2010 - The preliminary findings of the CREST study have so far failed to squelch the debate between proponents of the two different interventions for preventing stroke in patients with carotid stenosis. And at least one prominent vascular surgeon sees a most-unscientific phenomenon - “presenter bias” - as one reason the controversy is likely to continue.

November 23, 2010 – Boston Scientific will acquire Sadra Medical, a development-stage company in Los Gatos, Calif. Boston Scientific will pay $193 million up front, plus potential payments of up to $193 million upon achievement of specified regulatory and revenue-based milestones through 2016. The transaction is expected to be completed in the fourth quarter 2010 or early 2011.

November 23, 2010 – A device for peripheral transluminal angioplasty (PTA) and for capturing and containing embolic material during angioplasty in the lower extremities has been approved by the U.S. Food and Drug Administration (FDA). The Proteus device, by Angioslide, can be used in the femoral, iliac, iliofemoral, popliteal, tibial, peroneal and profunda arteries.

November 23, 2010 – Study results found significant differences in men and women older than 80 who underwent carotid surgical incision and carotid artery angioplasty and stenting. The results were presented by Caron B. Rockman, M.D., associate professor of surgery at the New York University School of Medicine at the VEITHsymposium.

November 23, 2010 - A new technique that combines the heat and energy of ultrasound with the highly targeted delivery of clot-busting drugs appears to be effective at treating patients with acute massive pulmonary embolism (PE).

The new treatment, called ultrasound-accelerated catheter-directed thrombolysis (CDT), was developed by the Ekos Corporation.

Exam-Link is a regional health information organization (RHIO) image-sharing platform from CoActiv. The LINK provides RHIOs and other affiliated, authorized medical facilities with immediate access to all patient exams, wherever and whenever the exam was performed. The vendor-neutral, cloud-based solution combines a pre-indexing feature that enables remote Web-based image access with all the advanced features and security of the company’s Exam-Vault archiving.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now